J&J Targets Oral, Skin And Hair Care In Latest Consumer Innovation Collaborations
This article was originally published in The Tan Sheet
In addition to consumer product projects funded through Johnson & Johnson Consumer Inc., the deals include early-stage discovery or pre-clinical partnerships with academia or biotechs facilitated by J&J’s Innovation Centers in London, Menlo Park, Calif., Boston and Shanghai.
You may also be interested in...
Sandoz US president Carol Lynch talked to Scrip about its changing US portfolio, which will emphasize biosimilars, as the Novartis unit is poised to divest most of its US generics portfolio to Aurobindo.
With Pataday Once Daily Relief (0.2% olopatadine) and Twice Daily (0.1%), Alcon adds allergy treatment to its lineup of OTC drops indicated for dry eye and redness. “Obviously, eye allergy will become a much bigger part of the portfolio for us,” says US vision care GM Sean Clark.
UK pharma announced that in 2021 it will close its manufacturing facility in Carlisle, PA, where around 260 people are employed making the Emergen-C line. It will move the manufacturing to its Guayama, PR, facility.